There May Be A Paradigm Shift In Generic Drug Labeling

Law360, New York (November 12, 2013, 12:42 PM EST) -- On Wednesday, Nov. 13, the U.S. Food and Drug Administration will publish a proposed rule in the Federal Register that will mandate that generic drug firms update their labels for drugs under approved abbreviated new drug applications to add warnings, precautions, adverse reactions, contraindications and certain other information even if the corresponding branded company has not implemented the same labeling change....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!